United States: WilmerHale Counsels TransMedics In Closing Of $51.2M Growth Financing To Transform Organ Transplant Therapy
Last Updated: June 9 2016

TransMedics, Inc., a medical technology company dedicated to improving quality, assessing viability and increasing the utilization of donor organs for transplantation announced the closing of $51.2 million growth equity financing.

TransMedics has developed the Organ Care System (OCS"), a revolutionary first-in-class technology and multi-organ platform with the potential to improve outcomes for transplant patients and to dramatically increase the number of transplantable organs worldwide. The OCS" is the only fully portable technology that maintains donor organs in a near-physiologic state outside of the human body and addresses the current limitations of cold storage.

The WilmerHale team on the transaction was led by Partner Rosemary Reilly and included Counsel Peter Osborn and Associate Byron Crowe.

Read TransMedics press release for more information.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By WilmerHale
By WilmerHale
By Alan Wilson, Jonathan Wolfman
By WilmerHale
By Anna Gaudoin
By Rachel Jacobson, Nathaniel Custer, Mark Hanin
By Leila Gaafar
By Paul M. Architzel, Anjan Sahni, Matthew Beville, Daniel Martin
By Glenn Luinenburg
By Rachel Jacobson, Andrew L. Spielman, Sarah Judkins
Font Size: